title: Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.
abstract: Despite advances in our understanding concerning the pathology of hypertension, the mechanisms that underpin the origin of hypertension remain to be fully elucidated. This enigma is, at least in part, due to inherent limitations of various animal models of hypertension. Here, we show the genetically modified Cyp1a1-Ren2 rat model, in which the onset and severity of angiotensin II-dependent hypertension can be tightly controlled, as an effective model for investigating increased sympathetic drive for the onset of hypertension. Cyp1a1-Ren2 rats were surgically prepared with radiotelemetric transmitters for the continuous measurement of arterial blood pressure (ABP). ABP was recorded in freely moving rats that were fed with either normal rat chow or a diet containing indole-3-carbinol (0.225% w/w) for 7 days to induce hypertension. Structural morphology of and endothelial NO synthase (eNOS) protein expression in heart and/or vascular tissue were analyzed. Sympathetic tone was estimated using spectral analysis of heart rate variability. The progressive induction of hypertension over 7 days was matched with a parallel increase in sympathetic tone. By day 7 of hypertension, eNOS expression in the mesenteric artery was elevated. However, the elevated ABP, sympathetic tone, and eNOS had not elicited gross morphological remodeling of the heart or vasculature. Importantly, both the increase in sympathetic tone and overexpression of eNOS within the vasculature were reversed when ABP was returned to normal. We conclude that the Cyp1a1-Ren2 rat provides an effective model for investigating specific adverse and transient changes in central sympathetic modulation of arterial blood pressure during the early onset of angiotensin-dependent hypertension.
authors: Department of Physiology, School of Medical Sciences, University of Otago, PO Box 913, Dunedin, New Zealand.
authors: Su Young
authors: SY
authors: Han
authors: Emily
authors: E
authors: Gray
authors: Gillian
authors: G
authors: Hughes
authors: Colin H
authors: CH
authors: Brown
authors: Daryl O
authors: DO
authors: Schwenke
mesh_terms: D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D001794:Blood Pressure; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics / Q000378:metabolism*; D006973:Hypertension / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008638:Mesenteric Arteries / Q000378:metabolism / Q000473:pathology; D009206:Myocardium / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000378:metabolism; D051381:Rats; D012083:Renin / Q000235:genetics / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000502:physiology*
chemical_list: C535029:Ren2 protein, rat; D052250:Nitric Oxide Synthase Type III; D019363:Cytochrome P-450 CYP1A1; D012083:Renin
references: J Renin Angiotensin Aldosterone Syst. 2006 Jun;7(2):74-86
references: 17083061
references: J Electrocardiol. 1994 Oct;27(4):333-7
references: 7815012
references: Eur J Endocrinol. 2013 May 02;168(6):845-52
references: 23482594
references: Am Heart J. 1996 Oct;132(4):779-82
references: 8831366
references: J Biol Chem. 2001 Sep 28;276(39):36727-33
references: 11448960
references: Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R818-28
references: 23535460
references: J Hum Hypertens. 2003 Apr;17(4):223-30
references: 12692566
references: Heart Fail Rev. 2001 Dec;6(4):265-76
references: 11447301
references: Curr Hypertens Rep. 2012 Jun;14(3):261-9
references: 22562144
references: Hypertens Res. 2011 Apr;34(4):431-40
references: 21228777
references: Br J Anaesth. 2004 Jul;93(1):105-13
references: 15121728
references: Psychiatry Res. 2000 Sep 25;96(1):1-13
references: 10980322
references: Am J Physiol Renal Physiol. 2007 Nov;293(5):F1584-91
references: 17715265
references: Circulation. 2001 Mar 6;103(9):1282-8
references: 11238274
references: Am J Physiol Renal Physiol. 2005 Apr;288(4):F810-5
references: 15585671
references: Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H422-30
references: 20511409
references: Otolaryngol Head Neck Surg. 2013 Jun;148(6):997-1002
references: 23520070
references: N Engl J Med. 2009 Aug 27;361(9):932-4
references: 19710497
references: Am J Physiol Renal Physiol. 2007 Jun;292(6):F1858-66
references: 17344186
references: Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1551-7
references: 15879305
references: Kidney Int. 1999 Aug;56(2):414-20
references: 10432379
references: Can J Cardiol. 2006 May 15;22(7):553-5
references: 16755308
references: J Clin Invest. 1996 Feb 15;97(4):1047-55
references: 8613528
references: Lancet. 2005 Jan 15-21;365(9455):217-23
references: 15652604
references: J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):69-81
references: 23462119
references: Curr Opin Cardiol. 2007 May;22(3):176-84
references: 17413273
references: Am J Cardiol. 2010 Feb 15;105(4):570-6
references: 20152255
references: Circulation. 2000 Nov 21;102(21):2607-10
references: 11085964
references: Proc Soc Exp Biol Med. 1960 Nov;105:213-6
references: 13706475
references: Am J Physiol Regul Integr Comp Physiol. 2002 Aug;283(2):R441-50
references: 12121857
references: Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H397-407
references: 20971763
references: Circulation. 2013 Jan 1;127(1):e6-e245
references: 23239837
references: Curr Hypertens Rep. 2010 Feb;12(1):39-46
references: 20425157
references: Am J Cardiol. 2003 Aug 15;92(4):400-5
references: 12914869
references: Eur Heart J. 2012 May;33(9):1058-66
references: 22507981
references: Clin Exp Hypertens. 1995 Jan-Feb;17(1-2):29-38
references: 7735276
references: J Hypertens. 1994 Nov;12(11):1225-34
references: 7868869
references: N Engl J Med. 2009 Aug 27;361(9):878-87
references: 19710486
references: Science. 1963 Jan 18;139(3551):210-5
references: 17772081
references: Hypertension. 2007 Feb;49(2):373-9
references: 17159083
references: Circulation. 2002 Apr 9;105(14):1656-62
references: 11940543
references: Int J Epidemiol. 2005 Oct;34(5):967-72; discussion 972-4, 975-8
references: 16143660
references: Circ J. 2013;77(4):857-63
references: 23514712
references: Circulation. 2007 Apr 17;115(15):1999-2005
references: 17389264
references: Br J Pharmacol. 2013 Feb;168(3):686-703
references: 22994554
references: Am J Hypertens. 2004 Mar;17(3):217-22
references: 15001194
references: Hypertension. 2013 May;61(5):1083-90
references: 23509081
references: Am J Hypertens. 2007 Dec;20(12):1297-304
references: 18047920
references: Hypertension. 1989 Oct;14(4):396-403
references: 2551821
references: Eur J Pharmacol. 2011 Sep 30;667(1-3):258-64
references: 21640096
references: Cleve Clin J Med. 2012 Jul;79(7):501-10
references: 22751635
references: Antioxid Redox Signal. 2008 Jun;10(6):1115-26
references: 18321209
references: Jpn Circ J. 1963 Mar;27:282-93
references: 13939773
references: Circ Res. 1964 Dec;15:511-21
references: 14243890
references: Hypertension. 2006 Nov;48(5):927-33
references: 17000931